U.S. Supreme Court
Dec. 2, 2009
Supreme Court Leans in Favor of Shareholders in Securities Fraud Case
Showing little sympathy for pharmaceutical giant Merck & Co, the U.S. Supreme Court seemed inclined Monday to rule for shareholders in a major class action securities fraud case.
Daily Journal Staff Writer
WASHINGTON - Showing little sympathy for pharmaceutical giant Merck & Co, the U.S. Supreme Court seemed inclined Monday to rule for shareholders in a major class action securities fraud case.
At issue is what level of knowledge plaintiffs need to have about the fraud before a two-year statute of limitations is triggered.
Shareholders sued Merck in 2003 for alleged ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In